Cognitive testing in the diagnosis of Parkinsonian disorders: A critical appraisal of the literature

Movement Disorders

Volumn 27, Issue 10, 2012, Pages 1243-1254

  Lee, Will ^a   Williams, David R ^a,b   Storey, Elsdon ^a,b  

^a ALFRED HOSPITAL   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Cognitive; Diagnosis; Neuropsychology; Parkinsonism

Indexed keywords

LEVODOPA;

APRAXIA; ARTICLE; COGNITION; COGNITIVE TESTING; CORTICOBASAL DEGENERATION; DEMENTIA; DEPTH PERCEPTION; DISEASE SEVERITY; EXECUTIVE FUNCTION; HUMAN; MEDLINE; MEMORY; NEUROLOGIC EXAMINATION; PARKINSON DISEASE; PARKINSONISM; PHONEME; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; SHY DRAGER SYNDROME; SPEECH; SYSTEMATIC REVIEW; WECHSLER MEMORY SCALE;

AGED; COGNITION DISORDERS; DATABASES, FACTUAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; NEUROPSYCHOLOGICAL TESTS; PARKINSONIAN DISORDERS; RETROSPECTIVE STUDIES;

EID: 84866295916     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25113     Document Type: Article

References (32)

1. Hughes AJ, Daniel SE, Ben-Shlomo Y, Lees AJ. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain. 2002; 125: 861-870.
2. Caslake R, Moore JN, Gordon JC, Harris CE, Counsell C. Changes in diagnosis with follow-up in an incident cohort of patients with parkinsonism. J Neurol Neurosurg Psychiatry. 2008; 79: 1202-1207.
3. Williams DR, Lees AJ. How do patients with parkinsonism present? A clinicopathological study. Intern Med J. 2009; 39: 7-12.
4. Litvan I, Bhatia KP, Burn DJ, et al. SIC task force appraisal of clinical diagnostic criteria for parkinsonian disorders. Mov Disord. 2003; 18: 467-486.
5. Wilcox RR: Comparing two groups. In: Basic Statistics-Understanding Conventional Methods and Modern Insights. New York: Oxford University Press; 2009: 196-197.
6. Litvan I, Bhatia KP, Burn DJ, et al. Movement Disorders Society Scientific Issues Committee Report: SIC Task force appraisal of clinical diagnostic criteria for parkinsonian disorders. Mov Disord. 2003; 18: 467-486.
7. McGee S. Simplifying likelihood ratios. J Gen Intern Med. 2002; 17: 647-650.
8. Ling H, O'sullivan SS, Holton JL, et al. Does corticobasal degeneration exist? A clinicopathological re-evaluation. Brain. 2010; 133: 2045-2057.
9. Pillon B, Blin J, Vidaihet M, et al. The neuropsychological pattern of corticobasal degeneration: comparing with progressive supranuclear palsy and Alzheimer's disease. Neurolology. 1995; 45: 1477-1483.
10. Meco G, Gasparini M, Doricchi F. Attentional functions in multiple system atrophy and Parkinson's disease. J Neurol Neurosurg Psychiatry. 1996; 60: 393-398.
11. Monza D, Soliveri P, Radice D, et al. Cognitive dysfunction and impaired organization of complex motility in degenerative parkinsonian syndromes. Arch Neurol. 1998; 55: 372-378.
12. Litvan I, Grimes DA, Lang AE et al. Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration. J Neurol. 1999; 246(Suppl 2): II/1-II/5.
13. Soliveri P, Monza D, Paridi D et al. Cognitive and magnetic resonance imaging aspects of corticobasal degeneration and progressive supranuclear palsy. Neurolology. 1999: 53: 502-507.
14. Wenning GK, Ben-Shlomo Y, Hughes A, Daniel SE, Lees A, Quinn NP. What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson's disease? J Neurol Neurosurg Psychiatry. 2000; 68: 434-440.
15. Soliveri P, Monza D, Paridi D, et al. Neuropsychological follow-up in patients with Parkinson's disease, striatonigral degeneration-type multisystem atrophy, and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry. 2000; 69: 313-318.
16. Lange KW, Tucha O, Alders GL et al. Differentiation of parkinsonian syndromes according to difference in executive functions. J Neurol Transm. 2003; 110: 983-995.
17. Dujardin K, Defebvre L, Krystkowiak P, Degreef JF, Destee A. Executive function differences in multiple system atrophy and Parkinson's disease. Parkinsonism Relat Disord. 2003; 9: 205-211.
18. Ozsancak C, Auzou P, Dujardin K, Quinn N, Destee A. Orofacial apraxia in corticobasal degeneration, progressive supranuclear palsy, multiple system atrophy and Parkinson's disease. J Neurol. 2004; 251: 1317-1323.
19. Bak TH, Crawford LM, Hearn VC, Mathuranath PS, Hodges JR. Subcortical dementia revisited: similarities and differences in cognitive function between progressive supranuclear palsy, corticobasal degeneration and multiple system atrophy. Neurocase. 2005; 41: 268-273.
20. Paviour DC, Winterburn D, Simmonds S, et al. Can the frontal assessment battery (FAB) differentiate bradykinetic rigid syndromes? Relation of the FAB to formal neuropsychological testing. Neurocase. 2005; 11: 274-282.
21. Bak TH, Caine D, Hearn VC, Hodges JR. Visuospatial functions in atypical parkinsonian syndromes. J Neurol Neurosurg Psychiatry. 2006; 77: 454-456.
22. Borroni B, Turla M, Bertasi V, Agosti C, Gilberti N, Padovani A. Cognitive and behavioural assessment in the early stages of neurodegenerative extrapyramidal syndromes. Arch Gerontol Geriatr. 2008; 47: 53-61.
23. Shelley BP, Hodges JR, Kipps CM, Xuereh JH, Bak TH. Is the pathology of corticobasal syndrome predictable in life? Mov Disord. 2009; 24: 1593-1599.
24. Kao AW, Racine CA, Quitania LC, Kramer JH, Christine CW, Miller BL. Cognitive and neuropsychiatric profile of the synucleinopathies: Parkinson's disease, dementia with Lewy bodies and multiple system atrophy. Alzheimer Dis Assoc Disord. 2009; 23: 365-370.
25. Brown RG, Lacomblez L, Landwehrmeyer BG et al. Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy. Brain. 2010; 133: 2382-2393.
26. Krishnan S, Mathuranath PS, Sarma S, Kishore A. Neuropsychological functions in progressive supranuclear palsy, multiple system atrophy and Parkinson's disease. Neurol India. 2006; 4: 268-272.
27. Cordato NJ, Halliday GM, Caine D, Morris JGL. Comparison of motor, cognitive and behavioral features in progressive supranuclear palsy and Parkinson's disease. Mov Disord. 2006; 21: 632-638.
28. Kertesz A, McMonagle P. Behavior and cognition in corticobasal degeneration and progressive supranuclear palsy. J Neurol Sci. 2010; 289: 138-143.
29. Williams DR, Lees AJ. Progressive supranuclear palsy:clinicopathological concepts and diagnostic challenges. Lancet Neurol. 2009; 8: 270-279.
30. Spreen O, Strauss E, eds. A Compendium of Neuropsychological Tests. New York: Oxford University Press; 1998: 171-231.
31. Bak TH, Mioshi E. A cognitive bedside assessment beyond the MMSE: the Addenbrooke's Cognitive Examination. Pract Neurol. 2007; 7: 245-249.
32. Williams DR, Holton JL, Strand C, et al. Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome. Brain. 2007; 130: 1566-1576.